KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Amgen (AMGN) Revenue (2016 - 2025)

Historic Revenue for Amgen (AMGN) over the last 17 years, with Q4 2025 value amounting to $9.9 billion.

  • Amgen's Revenue rose 858.46% to $9.9 billion in Q4 2025 from the same period last year, while for Dec 2025 it was $36.8 billion, marking a year-over-year increase of 995.39%. This contributed to the annual value of $36.8 billion for FY2025, which is 995.39% up from last year.
  • Per Amgen's latest filing, its Revenue stood at $9.9 billion for Q4 2025, which was up 858.46% from $9.6 billion recorded in Q3 2025.
  • Amgen's Revenue's 5-year high stood at $9.9 billion during Q4 2025, with a 5-year trough of $5.9 billion in Q1 2021.
  • In the last 5 years, Amgen's Revenue had a median value of $6.9 billion in 2023 and averaged $7.5 billion.
  • Its Revenue has fluctuated over the past 5 years, first crashed by 422.01% in 2021, then soared by 2317.83% in 2024.
  • Quarter analysis of 5 years shows Amgen's Revenue stood at $6.8 billion in 2021, then fell by 0.1% to $6.8 billion in 2022, then increased by 19.84% to $8.2 billion in 2023, then rose by 10.86% to $9.1 billion in 2024, then grew by 8.58% to $9.9 billion in 2025.
  • Its last three reported values are $9.9 billion in Q4 2025, $9.6 billion for Q3 2025, and $9.2 billion during Q2 2025.